The combination of SNO‐HSA‐PTX and US treatment (1 MHz, 2 W cm−2, 5 min) could significantly suppress the tumor growth of breast cancer mice by promoting the infiltration of intra‐tumoral CD4+/CD8+ T cells, and downregulating the population of Treg cells (Figure 2b). The gene discussed is CD8A; the disease is neoplasm.